CAMBRIDGE, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – announced the initiation of dosing in the global clinical study, PROMINENT. The Phase 3 study will evaluate the efficacy and safety of the investigational drug felzartamab compared to tacrolimus in adults diagnosed with primary membranous nephropathy (PMN). PROMINENT is designed to enroll approximately 180 adults with PMN and expected to readout in 2029. PMN is a severe antibody-mediated disease of the kidney that is a leading cause of nephrotic syndrome and carries a significant risk of kidney failure.
The 2025 update explores how evolving consumer interest in brain fog, coffee-enhanced wellness routines, and ingredient transparency is shaping the future of cognitive support.
The 2025 update explores how evolving consumer interest in brain fog, coffee-enhanced wellness routines, and ingredient transparency is shaping the future of cognitive support.
Differences in manufacturing processes impact the tolerability of intravenous immune globulin (IVIG) products GC Biopharma's manufacturing process reduces FXIa to undetectable levels – a critical...
"Harnessing the Power of the Immune System: How Cancer Immunotherapy and Oncolytic Virology Are Reshaping the Future of Oncology in a Digitally Driven Era"
BOSTON,...
Topical patch combines traditional botanicals like Wormwood and Ginger with transdermal delivery to support physical ease, flexibility, and everyday joint comfort.
Topical patch combines traditional botanicals like Wormwood and Ginger with transdermal delivery to support physical ease, flexibility, and everyday joint comfort.
FORT LAUDERDALE, Fla., June 25, 2025 /PRNewswire/ -- The 2025 Independent Grocers Financial Study, released today by the National Grocers Association (NGA) and FMS...
~Distributed more than 700 kgs of Glucon-D infused Golas at 100+ stadiums and playgrounds, in Hyderabad, Kolkata, Lucknow, and Mumbai~~Launches film to help combat...
Innovative needle-free technology empowers users to monitor glucose signals, oxygen saturation, and heart rate from home—without the discomfort or complexity of traditional tools.
Innovative needle-free technology empowers users to monitor glucose signals, oxygen saturation, and heart rate from home—without the discomfort or complexity of traditional tools.
Struggling with post-COVID symptoms? Access expert-led telehealth support to reclaim your health—limited workshop spots available.
DUNEDIN, Fla., June 24, 2025 /PRNewswire/ -- Millions of individuals suffering...
HONG KONG, June 24, 2025 /PRNewswire/ -- LiberNovo has officially launched its flagship ergonomic chair, Omni, on Kickstarter. Designed for professionals who spend long...
SANTA MONICA, Calif., June 24, 2025 /PRNewswire/ -- EarFun, the consistently awarded wireless audio brand is debuting a new kind of wireless earbuds called...